Intraoperative Scintigraphic Detection of Abdominal Endocrine Tumors

References

• Romer A. Educational services Inc., London 1960
   Google Scholar
• Anger H. Scintillation camera. Rev Sci Instrum 1958; 29: 27–33
   Web of Science ®Google Scholar
• Larsson S. A. Gamma camera emission tomography. Development and properties of a multisectional emission computed tomography system. Acta Radiol Suppl 1980; 363: 1–75
   Google Scholar
• Westlin J. E. Studies in nuclear medicine of the in vivo localization and characterisation of neuroendocrine tumours. Acta Universitatis Upsaliensis, UppsalaSweden 1992
   Google Scholar
• Marinelli L. D., Goldschmidt B. The concentration of 32P in some superficial tissues of living patients. Radiology 1942; 39: 454–63
   Google Scholar
• Low-Beer B. V.A., Bell H. G., McCorkle H. J., Stone R. S. Measurement of radioactive phosphorus in breast tumors in situ: a possible diagnostic procedure. Radiology 1946; 47: 492–3
   PubMed Web of Science ®Google Scholar
• Selverstone B., Sweet W. H., Robinson C. V. The clinical use of radioactive phosphorus in the surgery of brain tumors. Ann Surg 1949; 47: 492–3
   Google Scholar
• Marcus C. S. Silicone probes for physiological studies: experience, limitations, and perspectives. Semiconductor detectors in medicine (Conference 730321). U.S. Atomic Energy Commision, Oak Ridge 1973; 189–236
   Google Scholar
• Harris C. C., Bigelow R. R., Francis J. E., Kelley G. G., Bell P. R. A CsI(TI)-crystal surgical scintillation probe. Nucleonics 1956; 14: 102–8
   Google Scholar
• Lennquist S., Persliden J., Smeds S. The value of intraoperative scintigraphy as a routine procedure in thyroid carcinoma. World J Surg 1988; 12: 586–92
   Google Scholar
• Woolfenden J. H., Barber H. B. Radiation detector probes for tumor localization using tumor-seeking radioactive tracers. AJR Am J Roentgenol 1989; 153: 35–9
   PubMedGoogle Scholar
• Colton C. L., Hardy J. G. Evaluation of sterilizable radiation probe as an aid to the surgical treatment of osteid-osteoma. J Bone Joint Surg Am 1983; 65: 1019–22
   Google Scholar
• Kirchner B., Hillman A., Lottes G., Sciuk J., Bartenstein P., Winkelmann W., et al. Intraoperative, probe-guided crettage of osteid osteoma. Eur J Nucl Med 1993; 20: 609–13
   Google Scholar
• Eisen H. N., Keston A. S. The immunologic reactivity of bovine serumalbumin labeled with trace-amounts of radioactive iodine (I-131). J Immunol 1950; 63: 71–80
   Google Scholar
• Pressman D., Korngold L. The in vivo localization of anti-Wagner-osteogenic sarcoma antibodies. Cancer 1953; 6: 619–23
   PubMed Web of Science ®Google Scholar
• Pressman D., Day E. D., Blau M. The use of paired labeling in the determination of tumorlocalizing antibodies. Cancer Res 1957; 17: 845–50
   PubMed Web of Science ®Google Scholar
• Wilder R. B., DeNardo G. L., DeNardo S. J. Radioimmunotherapy: Recent results and future directions. J Clin Oncol 1996; 14: 1383–400
   PubMed Web of Science ®Google Scholar
• Goldenberg D. M., Preston D. F., Primus F. J., Hansen H. J. Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res 1974; 34: 1–9
   PubMed Web of Science ®Google Scholar
• Mach J. P., Carrel S., Merenda C., Sordat B., Cerottini J-C. In vivo localization of radiolabeled antibodies to carcioembryonic antigen in human colon carcinoma grafted into nude mice. Nature 1974; 248: 704–6
   PubMed Web of Science ®Google Scholar
• Goldenberg D. M., de Land F., Kimm E. E. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978; 298: 1384–8
   PubMed Web of Science ®Google Scholar
• Epenetos E. E., Mather S., Granowska M., Nimmon C. C., Hawkins L. R., Britton K. E., et al. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 1982; II: 999–1004
   Google Scholar
• Goldenberg D. M., Larson S. M. Radioimmunodetection in cancer identification. J Nucl Med 1992; 33: 803–14
   PubMed Web of Science ®Google Scholar
• Goldenberg D. M. Introduction to the sixth conference on radioimmunodetection and radioimmunotherapy of cancer. Cancer 1997; 80: 2343–4
   Google Scholar
• Rodwell J. D. Engineering monoclonal antibodies. Nature 1989; 342: 99–100
   PubMed Web of Science ®Google Scholar
• Winter G., Harris W. J. Humanized antibodies. Trends Pharmacol Sci. 1993; 14: 139–43
   PubMed Web of Science ®Google Scholar
• Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., et al. SMS 209–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982; 31: 1133–40
   PubMed Web of Science ®Google Scholar
• Coy D. H., Taylor J. E. Receptor-specific Somatostatin analogs: correlations with biological activity. Metabolism 1996; 45: 21–3
   PubMed Web of Science ®Google Scholar
• Perkins A. Peroperative nuclear medicine. Eur J Nucl Med 1993; 20: 573–5
   Google Scholar
• Kairemo K. J.A. Radioimmunoimaging in clinical oncology: Possibilities and limitations. Medical faculity, univerity of Helsinki, Helsinki 1993
   Google Scholar
• Rockoff S. D., Goodenough D. J., McIntire K. R. Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res 1980; 40: 3054–8
   PubMed Web of Science ®Google Scholar
• Abdel-Nabi H. H., Schwarts A. N., Goldfogel G. Colorectal tumors: scintigraphy with 111In anti-CEA monoclonal antibody and correlation with surgical histopathologic and immunohistochemical findings. Radiology 1988; 166: 747–52
   PubMed Web of Science ®Google Scholar
• Kramer E. L., Sanger J. J., Walsh C. Contribution of SPECT to imaging of gastrointestinal adenocarcinoma with 111In labeled antiCEA monoclonal antibody. AJR Am J Roenigenol 1988; 151: 697–703
   PubMed Web of Science ®Google Scholar
• Lind P., Langsteger W., Költringer P., Lechner P., Beham A., Arian K. Schad, et al. Tc99mlabeled monoclonal anticarcinoembryonic antigen antibody (BW 431 26). Scand J Gastroenterol 1989; 24: 1205–11
   PubMed Web of Science ®Google Scholar
• Siccardi A. G., Buraggi G. L., Callegaro L., Colella A. C., De Filippi P. G., Galli G., et al. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of anti-carcinoembryonic antigen monoclonal antibody: A multicenter study. Cancer Res 1989; 49: 3095–103
   PubMed Web of Science ®Google Scholar
• Waddington W. A., Davidson B. R., Todd-Prokopek A., Boulus P. B., Short M. D. M. D. Evaluation of a technique for the intraoperative detection of a radiolabeled monoclonal antibody against colorectal cancer. Eur J Nucl Med 1991; 18: 964–72
   Google Scholar
• Goldenberg D. M., Goldenberg H., Sharkey R. M., Higginbotham-Ford E., Lee R., Swayne L. C., et al. Clinical studies of cancer radioimmunodetection with carcinoembryoenic antigen monoclonal antibody fragments labeled with 123I and 99mTc. Cancer Res 1990; 50: 909–21
   PubMed Web of Science ®Google Scholar
• Oosterwijk E., Bander N. H., Divgi C. R., Welt S., Wakka J. C., Finn R. D., et al. Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250. J Clin Oncol 1993; 11: 738–50
   PubMed Web of Science ®Google Scholar
• Lövquist A. On the use of ⁷⁶Br for radioimmuno P.E.T., experimental studies. Acta universitatis Upsaliensis, UppsalaSweden 1997
   Google Scholar
• Aitken D. E., Hinkle G. H., Thurstone M. O. A gamma detecting probe for radioimmune detection of CEA producing tumors. Dis Colon Rectum 1984; 27: 279–82
   Google Scholar
• Aitken D. E., Thurstone M. O., Hinkle G. H. Portable gamma probe for radioimmuno localization of experimental colon xenografts. J Surg Res 1984; 36: 480–9
   Google Scholar
• Nieroda C. A., Siddiqi M. A., Hinkle G. H. An assessment of prolonged reactivity of seven monoclonal antibodies against CX-1 tumor xenografts using a hand held gamma detecting probe. J Invest Surg 1989; 2: 227–40
   Google Scholar
• Reuter M., Montz R., de Heer K., Schäfer H., Klapdor R., Desler K., et al. Detection of colorectal carcinomas by intraoperative RIS in addition to preoperative RIS: surgical and immunohistochemical findings. Eur J Med 1992; 19: 102–9
   Google Scholar
• Martin D. T., Hinkle G. H., Tuttle S., Olsen J. H., Nabi H., Houchens D., et al. Intraoperative radioimmunodetection of colorectal tumor with hand held radiation detector. Am J Surg 1985; 150: 672–5
   PubMed Web of Science ®Google Scholar
• Arnold M. W., Schneebaum S., Berens A., Mojzisik C., Hinkle G., Martin J. E.W. Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 1992; 112: 624–30
   PubMed Web of Science ®Google Scholar
• Tuttle S. E., Jewel S. D., Mojzisik C. M. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand held gamma probe and MAb B72.3: comparison in vivo gamma probe counts with MAb radiolocalization. Int J Cancer 1988; 42: 352–8
   Google Scholar
• Sickle-Santanello B. J., O'Dwyer P. J., Mojzisik C. Radioimmunoguided surgery using the monoclonal antibody B 72.3 in colorectal tumors. Dis Colon Rectum 1987; 30: 761–4
   PubMed Web of Science ®Google Scholar
• Sardi A., Workman M., Mojzisik C. Intraabdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (Rigs system). Arch Surg 1989; 124: 55–9
   PubMed Web of Science ®Google Scholar
• Nieroda C. A., Mojzisik C., Sardi A. Staging of carcinoma of the breast using a hand held gamma detecting probe and monoclonal antibody B72.3. Surg Gynecol Obstet 1989; 36: 35–41
   Google Scholar
• Henley D. J., van Heerden J. A., Grant C. S., Carney J. A., Carpenter P. C. Adreno cortical carcinoma-A continuing challenge. Surgery 1983; 94: 926–31
   PubMed Web of Science ®Google Scholar
• Cohn K., Gottesman L., Brennan M. Adrenalcortical carcinoma. Surgery 1986; 100: 1170–7
   PubMed Web of Science ®Google Scholar
• Hutter A. M., Kayhoe D. E. Adrenal cortical carcinoma: results of treatment with o,p ‘DDD in 138 patients. Am J Med 1966; 41: 581–92
   PubMed Web of Science ®Google Scholar
• Ostuni J. A., Roginsky M. S. Metastatic adrenal cortical carcinoma: documented cure with combined chemotherapy. Arch Intern Med 1975; 135: 1257–8
   PubMedGoogle Scholar
• Eriksson B., Öberg K., Curstedt T., Hemmingsson A., Johansson H., Lindh E. Treatment of hormone-producing adrenocortical cancer with o,p'DDD and streptozocin. Cancer 1987; 59: 1398–403
   Google Scholar
• Nader S., Hickey R. C., Sellin R. V., Samaan N. A. Adrenocortical carcinoma a study of 77 cases. Cancer 1983; 52: 707–11
   PubMed Web of Science ®Google Scholar
• Gröndal S., Cedermark B., Eriksson B., Grimelius L., Harach R., Kristoffersson A. Adrenocortical carcinoma: a retrospective of a rare tumor with poor prognosis. Eur J Surg Oncol 1990; 16: 500–6
   Google Scholar
• Pommier R. F., Brennan M. F. An eleven-year experience with adrenal carcinoma. Surgery 1992; 112: 963–70
   PubMed Web of Science ®Google Scholar
• Francis I. R., Gross M. D., Shapiro B., Korobkin M., Quint L. E. Integrated imaging of adrenal disease. Radiology 1992; 184: 1–13
   Google Scholar
• Williams E. D., Sandler M. The classification of carcinoid tumors. Lancet 1963; 1: 238–9
   PubMed Web of Science ®Google Scholar
• Thorson A. H. Studies on carcinoid disease. Acta Med Scand 1958; 334: 7–132
   Google Scholar
• Åkerström G. Carcinoid tumors of the Gut: Diagnosis and treatment. Acta Chir Austriaca 1992; 24: 88–93
   Google Scholar
• Öberg K., Eriksson B. The role of interferons in the management of carcinoid tumors. Acta Oncol 1991; 30: 519
   PubMed Web of Science ®Google Scholar
• Cockey B. M., Fichman E. K., Jones B., Siegelman S. S. Computed tomography of abdominal carcinoid tumor. J Comput Assist Tomogr 1985; 9: 38
   PubMed Web of Science ®Google Scholar
• Andersson T., Eriksson B., Hemmingsson A., Lindgren P. G., Öberg K. Percutaneous ultrasonography-guided cutting biopsy from liver metastases of endocrine gastrointestinal tumors. Ann Surg 1987; 206: 728
   PubMed Web of Science ®Google Scholar
• Westlin J. E., Tiensuu-Janson E., Ahlström H., Nilsson T., Öhrvall U., Öberg K. Scintigraphy using an 111-Indium labelled somatostatin analogue for localization of neuroendocrine tumors. Antibody, Immunoconj Radiopharm 1992; 5: 367–84
   Google Scholar
• Kwekkeboom D. J., Krenning E. P., Bakker W. H., Oei H. Y., Kooij P. P.M., Lamberts S. W.J. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993; 20: 283–92
   Google Scholar
• Grimelius L., Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol 1980; 3: 3–12
   PubMedGoogle Scholar
• Wilander E., Lundqvist M. L., Öberg K. Gastrointestinal carcinoid tumors; Histogenic, histochemical, immuno histochemical, clinical and therapeutic aspects. Prog Histochem Cytochem 1989; 19: 1–88
   PubMedGoogle Scholar
• Kent R. B., van Heeren J., Nejland L. Non functioning islet cell tumors. Ann Surg 1981; 193: 185–90
   PubMed Web of Science ®Google Scholar
• Moertel G. C., Hanley J. A., Johnsson L. A. Streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N Engl J Med 1980; 303: 1189–94
   PubMed Web of Science ®Google Scholar
• Åkerström G., Juhlin C. Surgical treatment of pancreatic tumors. Diagn Oncol 1992; 2: 332–7
   Google Scholar
• Lamberts S. W.J., Hofland L. J., van Koetsveld P. M., Reubi J. C., Bruining H. A., Bakker W. H., et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 1990; 71: 566–74
   PubMed Web of Science ®Google Scholar
• Krenning E. P., Kwekkeboom D. J., Bakker W. H., Breeman W. A.P., Kooij P. P.M., Oei H. Y., et al. Somatostatin receptor scintigraphy with ‘111In-DTPA-D-Phe1’- and ‘123I-Tyr3’-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716–31
   PubMedGoogle Scholar
• van-Eijck C. H., Lamberts S. W., Lemaire L. C., Jeekel H., Bosman F. T., Reubi J. C., et al. The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors. Ann Surg 1996; 224: 119–24
   Google Scholar
• Newsome H. H. Multiple endocrine adenomatosis. Surg Clin North Am 1974; 54: 387–93
   Google Scholar
• Ballard H. S., Frame B., Hartsock R. J. Familial multiple endocrine adenomatosis- peptic ulcer complex. Medicine (Baltimore) 1964; 43: 4811–6
   Google Scholar
• Tomlinson S., O'Riordan J. H.L., Grahmene-Jones E. Multiple endocrine adenomatosis and peptic ulcer. Proc R Soc Med 1973; 60: 445–6
   Google Scholar
• Larsson C., Skogseid B., Öberg K., Nakamura Y., Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85–7
   PubMed Web of Science ®Google Scholar
• Skogseid B., Eriksson B., Åkerström G., Rastad J., Öberg K. Screening for multiple endocrine neoplasia type 1 syndrome. Diagn Oncol 1993; 3: 91–5
   Google Scholar
• Åkerström G. Surgery in the MEN-1 syndrome. Surgery 1996; 1: 1531–7
   Google Scholar
• Thompson N. W. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 1995; 238: 269–80
   Google Scholar
• Grama D., Skogseid B., Wilander E., Eriksson B., Mårtensson H., Cedermark B., et al. Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg 1992; 16: 611–8
   PubMed Web of Science ®Google Scholar
• Klöppel G., Willemer S., Stamm B., Hacki W. H., Heitz P. U. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer 1986; 57: 1824–32
   PubMed Web of Science ®Google Scholar
• Skogseid B., Eriksson B., Lundqvist G., Lörelius L. E., Rastad J., Wide L., et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73: 281–7
   PubMed Web of Science ®Google Scholar
• Skogseid B., Grama D., Rastad J., Eriksson B., Lindgren P. G., Ahlström H., et al. Operative tumor yield obviates preoperative pancreatic tumour localization in multiple endocrine neoplasia type 1. J Intern Med 1995; 238: 281–8
   Google Scholar
• Thulin L., Samnegård H., Tydén G., Long D. H., Efendic' S. Efficiency of somatostatin in a patient with carcinoid syndrome. Lancet 1978; 2: 43
   PubMed Web of Science ®Google Scholar
• Rougier P. V., Calmettes C., Laplanche A. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma. Cancer 1983; 51: 855–62
   PubMedGoogle Scholar
• Berche C., Mach J. P., Lumbroso J. D. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J 1982; 285: 1447–51
   PubMed Web of Science ®Google Scholar
• Hoefnagel C. A., Delprat C. C., Zauw D., van Der Schoot J. B. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 1988; 13: 159–65
   Google Scholar
• Cabezas R. C., Berna L., Estorch M., Carrio I., Garcia-Ameijeiras A. Localization of metastases from medullary thyroid carcinoma using different methods. Henry Ford Hosp Med J 1989; 37: 168–72
   Google Scholar
• Juhlin C., Johansson H., Holmdahl R., Gylfe E., Larsson R., Rastad J., et al. Monoclonal anti-parathyroid antibodies interfering with a Ca2+-sensor of human parathyroid cells. Biochem Biophys Res Commun 1987; 143: 570–4
   PubMed Web of Science ®Google Scholar
• Juhlin C., Holmdahl R., Johansson H., Rastad J., Åkerström G., Klareskog L. Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci USA 1987; 84: 2990–4
   PubMed Web of Science ®Google Scholar
• Joseph U., Seesko H. G., Neumann K., Cance W., Wells S., Rothmund M. Immunohistochemical studies on specificity and affinity of the BB5-antibody against human parathyroid tissue. Exp Clin Endocrinol 1994; 120: 455–9
   Google Scholar
• Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7
   PubMed Web of Science ®Google Scholar
• Holmdahl R., Moran T., Andersson M. A rapid and efficient immunization protocl for production of monoclonal antibodies reactive with autoantigenes. J Immunol Meth 1985; 83: 379–84
   PubMed Web of Science ®Google Scholar
• Juhlin C., Rastad J., Klareskog L., Grimelius L., Åkerström G. Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am J Pathol 1989; 135: 321–8
   PubMed Web of Science ®Google Scholar
• Backlin C., Juhlin C., Grimelius L., Rastad J., Åkerström G. Monoclonal antibodies recognizing normal and neoplastic human adrenal cortex. Endocr pathol 1995; 1: 21–34
   Google Scholar
• Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., et al. Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77–9
   PubMed Web of Science ®Google Scholar
• Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495–9
   PubMed Web of Science ®Google Scholar
• Mulvihill S., Pappas T. N., Passaro E., Debas H. T. The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 1986; 100: 467–76
   PubMed Web of Science ®Google Scholar
• Reubi J. C., Häcki W. H., Lamberts S. W.J. Hormone-producing gastrointestinal tumors contain high density of somatostatin receptors. J Clin Endocrinol Metab 1987; 65: 1127–34
   PubMed Web of Science ®Google Scholar
• Reubi J. C., Kvols L., Krenning E., Lamberts S. W.J. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 9: 78–81
   Google Scholar
• Reubi J. C., Kvols L. K., Waser B., Nagorney D. M., Heitz P. U., Charboneau J. W., et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50: 5969–77
   PubMed Web of Science ®Google Scholar
• Lamberts S. W.J., van der Lely A. J., de Herder W. W., Hofland L. J. Octreotide. N Engl J Med 1996; 334: 246–54
   PubMed Web of Science ®Google Scholar
• Kvols L. K., Moertel C. G., O'Conell M. J., Schutt A. J., Rubin J., Hahn R. G. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
   PubMed Web of Science ®Google Scholar
• Eriksson B., Öberg K., Andersson T., Lundqvist G., Wide L., Wilander E. Treatment of malignant endocrine pancreatic tumors with a new longacting somatostatin analogue, SMS 201–995. Scand J Gastroenterol 1988; 23: 508–12
   PubMed Web of Science ®Google Scholar
• Wynick D., Bloom S. R. The use of the long acting somatostatin analogue octreotide in the treatment of gut neuroendocrine tumors. J Clin Endocrinol Metab 1991; 73: 1–3
   PubMedGoogle Scholar
• Öberg K., Norheim I., Theodorsson E. Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide. Acta Oncol 1991; 30: 503–7
   PubMed Web of Science ®Google Scholar
• Heiman M. L., Murphy W. A., Coy D. H. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenhypophysis. Neuroendocrinology 1987; 45: 429–36
   Google Scholar
• Anthony L., Johnsson D., Hande K., Shaff M., Winn S., Krozely M., et al. Somatostatin analogue phase I trials in neuroendocrineneoplasms. Acta Oncol (Madr) 1993; 32: 217–23
   PubMed Web of Science ®Google Scholar
• Cai R. Z., Szoke B., Lu R., Fu D., Redding T. W., Schally A. V. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci USA 1986; 83: 1896–900
   PubMed Web of Science ®Google Scholar
• Poston G. J., Schally A. V., Schally A. M., Guillou P. J. Phase one study on the use and tolerance of somatostatin analogue RC-160 in the treatment of patients with advanced exocrine pancreatic cancer. Gut 1991; 32: a342–A343
   Google Scholar
• Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 1992; 89: 251–5
   PubMed Web of Science ®Google Scholar
• Yasuda K., Rens-Domiano S., Breder C. D., Law S. F., Saper C. B., Reisine T., et al. Cloning of novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J Biol Chem 1992; 267: 20422–8
   PubMed Web of Science ®Google Scholar
• Reubi J. C., Schaer J. C., Waser B., Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994; 54: 3455–9
   PubMed Web of Science ®Google Scholar
• Bruno J. F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of brain-specific somatostatin receptor. Proc Natl Acad Sci USA 1992; 89: 11151–5
   PubMed Web of Science ®Google Scholar
• Yamada Y., Reisine T., Law S. F., Ihara Y., Kubota A., Kagimoto S., et al. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 1992; 6: 2136–42
   PubMed Web of Science ®Google Scholar
• Yamada Y., Kagimoto S., Kubota A., Yasuda K., Masuda K., Someya Y., et al. Cloning, functional expression and pharmacological characterization of fourth (hSSTR4) and fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993; 195: 844–52
   PubMed Web of Science ®Google Scholar
• Patel Y. C., Srikant C. B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5). Endocrinol 1994; 135: 2814–7
   PubMed Web of Science ®Google Scholar
• Patel Y. C. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997; 20: 348–67
   PubMed Web of Science ®Google Scholar
• Reubi J. C., Maurer R., von Werder K., Torhorst J., Klijn J. G.M., Lamberts S. W.J. Somatostatin receptors in human endocrine tumors. Cancer Res 1987; 47: 551–8
   PubMed Web of Science ®Google Scholar
• Krenning E. P., Bakker W. H., Breeman W. A.P., Koper J. W., Kooij P. P.M., Ausema L., et al. Localisation of endocrine related tumors with radioiodinated analogue of somatostatin. Lancet 1989; 1: 242–4
   PubMed Web of Science ®Google Scholar
• Lamberts S. W.J., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246–9
   PubMed Web of Science ®Google Scholar
• Bakker W. H., Krenning E. P., Breeman W. A., Kooij P. P.M., Reubi J. C., Koper J. W., et al. In vivo use of a radioiodinated somatostatin anlogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med 1991; 32: 1184–9
   PubMed Web of Science ®Google Scholar
• Krenning E. T., Bakker W. H., Kooij P. P.M., Breeman W. A.P., Oei H. Y., de Jong M., et al. Somatostatin receptor scintigraphy with Indium-111-DPTA-D-Phe-1-Octreotide in man: metabolism, dosimetri and comparison with Iodine-123-Tyr-3-Octreotide. J Nucl Med 1992; 33: 652–8
   PubMed Web of Science ®Google Scholar
• Tiensuu-Janson E., Ahlström H., Andersson T., Öberg K. Octreotide and interferon alpha: A new combination for the treatment of malignant carcinoid tumors. Eur J Cancer 1992; 10: 1647–50
   Google Scholar
• Schirmer W. J., O'Dorisio T. M., Schirmer T. P., Mojzisik C. M., Hinkle G. H., Martin E. W. Intraoperative localization of neuroendocrine tumors with 125I-Tyr(3)-octreotide and a hand-held gamma-detection probe. Surgery 1993; 114: 745–52
   PubMed Web of Science ®Google Scholar
• Woltering E. A., Barrie R., O'Dorioso T. M., O'Dorioso M. S., Nance R., Cook D. M. Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection. Surgery 1994; 116: 1139–47
   PubMed Web of Science ®Google Scholar
• Ahlman H., Wängberg B., Tisell L. E., Nilsson O., Fjälling M., Forsell-Aronsson E. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection. Br J Surg 1994; 81: 1144–9
   PubMedGoogle Scholar
• Leibovitz A., McCombs W. M., Johnston D., McCoy C. E., Stinson J. C. New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex. J Natl Cancer Inst 1973; 51: 691–7
   PubMedGoogle Scholar
• Unsgaard G., Larsen B., Dalen A., Vik R., Ringkjöb R. A new technique to register proliferation of clonogenic cells from brain tumors. J Neurooncol 1985; 3: 203–9
   PubMed Web of Science ®Google Scholar
• Hunter W. M., Greenwood P. C. Preparation of 131I-labelled human growth hormone of high specific activity. Nature 1962; 194: 495–6
   PubMed Web of Science ®Google Scholar
• Stanworth D. R., Turner M. W. Immunochemical analysis of immunoglobulins and their sub-units. Handbook of exprimental immunology, D. M. Weir. Blackwell, OxfordUK 1986; 1–6
   Google Scholar
• Bakker W. H., Albert R., Bruns C., Breeman W. A.P., Hofland L. J., Marbach P., et al. ‘111In-DTPA-D-Phe1’-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabelling and in vivo validation. Life Sci. 1991; 49: 1583–91
   PubMed Web of Science ®Google Scholar
• Bakker W. H., Krenning E. P., Breeman W. A., Koper J. W., Koij P. P., Reubi J. C., et al. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 1990; 31: 1501–9
   PubMed Web of Science ®Google Scholar
• Westlin J. E., Ahlstrom H., Yla-Jaaski J., Öberg K., Nilsson S. Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumours. Acta Oncol 1993; 32: 171–6
   PubMed Web of Science ®Google Scholar
• Wilander E. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumours. Acta Oncol Stockholm 1989; 28: 363–9
   PubMed Web of Science ®Google Scholar
• Keenan A. M., Harbert J. C., Larsen S. M. Monoclonal antibodies in nuclear medicine. J Nucl Med 1985; 26: 531–7
   PubMed Web of Science ®Google Scholar
• Sullivan D. C., Silva J. S., Cox C. E. Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen (CEA) antibodies in patients with cancer. Invest Radiol 1982; 17: 350–5
   PubMedGoogle Scholar
• Halpern S., Stern P., Hagan P. Labeling of monoclonal antibodies with indium-111: technique and advantages compared to radioiodine labeling. Radioimmunoimaging and radioimmunotherapy, S. W. Burchiel, B. A. Rhodes. Elsevier science, New York 1983; 197–205
   Google Scholar
• Hagan P. L., Alpern S. E., Chen A. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. J Nucl Med 1985; 26: 1418–23
   Google Scholar
• Gröndal S., Eriksson B., Hagenäs L., Werner S., Curstedt T. Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol (Copenh) 1990; 122: 656–63
   PubMedGoogle Scholar
• Smith-Jones P., Bischof C., Leimer M., Gludovacs D., Angelberger P., Pangeri T., et al. “Mauritius” a novel tumor diagnostic and therapeutic somatostatin analog. Cancer Res, (submitted)
   Google Scholar